Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
21,691,451
-
Share change
-
-5,756,362
-
Total reported value
-
$100,862,746
-
Put/Call ratio
-
687%
-
Price per share
-
$4.65
-
Number of holders
-
85
-
Value change
-
-$33,390,293
-
Number of buys
-
52
-
Number of sells
-
20
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2016
As of 31 Dec 2016,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,691,451 shares.
The largest 10 holders included
BRIDGER MANAGEMENT, LLC, FMR LLC, VANGUARD GROUP INC, UBS ASSET MANAGEMENT AMERICAS INC, BlackRock Fund Advisors, RA CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., COLUMBUS CIRCLE INVESTORS, STATE STREET CORP, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.